Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Alkermes plc ALKS

Healthcare Biotechnology
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALKS)

Alkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1

PR Newswire 19 hours ago

Alkermes to Report First Quarter Financial Results on May 1, 2024

PR Newswire 7 days ago

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

PR Newswire April 9, 2024

Alkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Society

PR Newswire April 8, 2024

Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

PR Newswire March 7, 2024

Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024

PR Newswire February 15, 2024

Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 15, 2024

PR Newswire February 8, 2024

Alkermes to Present at the 42nd Annual J.P. Morgan Healthcare Conference

PR Newswire January 3, 2024

Alkermes Announces Topline Results From Long-Term, Open-Label Safety and Durability of Treatment Effect Study of LYBALVI® (olanzapine and samidorphan)

PR Newswire January 3, 2024
View More News ››

Opinion & Analysis (NDAQ:ALKS)

VistaGen's fast-acting antidepressant targets multibillion-dollar market

The Life Sciences Report April 27, 2017

3 Biotech ETFs Rally On Merger News

Benzinga.com  December 8, 2014
View More Opinion ››

Bullboard Posts (NDAQ:ALKS)

EMERGING PARADIGMS IN TREATMENT OF MELANOMA!

$ALKS $NKTR $MGNX $CTMX $IDYA  Melanoma, a form of skin cancer, accounts for about 1% of skin cancers but is responsible for...
AviseAnalytics - January 26, 2022

Eli's exit

(Source: Bloomberg, May 23)Alkermes suffered a blow after Eli Lilly $ Co. made it clear that they were no longer going to part take in...
investology - May 25, 2008

A BIG BOOYAH BOYS

BUY AGX.V
Cheerss - January 5, 2006

ALKS --- Fresh July High ---

ALKS --- Fresh July High --- ALKS the stock shows strength today as it pushed higher above yesterday's high to record fresh July...
stocksinnews - July 19, 2005

too bad CDN biotechs cannot get this high

before a FDA non-approval so easy money gets made. therefore, they are always a good swing trade with every NR before it comes out...
japa8 - July 1, 2002
View more Bullboard ››

LNG Energy Group Corp.

LNG Energy Group Corp.

LNG Energy Group Corp is a Canada-based company, which is focused on the acquisition and development of natural gas ...
View More »